Browse Items (5 total)

https://aihp.org/wp-content/uploads/2021/12/pdib-049a-mapharsen.jpg
Parke Davis collectible ink blotter from the 1930s advertising Mapharsen, a treatment for syphilis. It is indicated in early, late, latent, congenital, cardiovascular, and "in pregnancy" related treatment of syphilis. The advertisement promises…

https://aihp.org/wp-content/uploads/2021/12/pdib-050a-mapharsen.jpg
Parke Davis collectible ink blotter from the 1940s advertising Mapharsen, a treatment for syphilis. It is indicated in early, late, latent, congenital, cardiovascular, and "in pregnancy" related treatment of syphilis. The advertisement promises…

https://aihp.org/wp-content/uploads/2022/01/pdib-051a-mapharsen.jpg
Parke Davis collectible ink blotter from the 1940s advertising Mapharsen, a treatment for syphilis. The advertisement notes that this antisyphilitic is low in toxicity, permitting treatment with small doses of arsenic. No neutralization prior to…

https://aihp.org/wp-content/uploads/2022/01/pdib-052a-mapharsen.jpg
Parke Davis collectible ink blotter from the 1940s advertising Mapharsen, a treatment for syphilis. The advertisement notes that this treatment has maximum therapeutic effect and minimum untoward reaction; it also highlights Mapharsen's clinical…

https://aihp.org/wp-content/uploads/2022/01/pdib-053a-mapharsen.jpg
Parke Davis collectible ink blotter from the 1940s advertising Mapharsen, a treatment for syphilis. The advertisement notes that this treatment has maximum therapeutic effect and minimum untoward reaction; it also highlights Mapharsen's clinical…
Output Formats

atom, dc-rdf, dcmes-xml, json, omeka-xml, rss2